BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38279417)

  • 1. RNF213 inhibits migration in lung adenocarcinoma cell.
    Liu X; Zeng H; Li Z; Wei C; Zhang Z; Liu X; Chen N
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):286-292. PubMed ID: 38279417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E
    Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L
    Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
    Front Oncol; 2021; 11():754290. PubMed ID: 34745988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
    Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
    Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF213 suppresses carcinogenesis in glioblastoma by affecting MAPK/JNK signaling pathway.
    Wang X; Ye M; Wu M; Fang H; Xiao B; Xie L; Zhu X
    Clin Transl Oncol; 2020 Sep; 22(9):1506-1516. PubMed ID: 31953610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
    Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
    Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma.
    Zhou H; Zhu Y; Qi H; Liang L; Wu H; Yuan J; Hu Q
    Aging (Albany NY); 2021 Feb; 13(4):5312-5331. PubMed ID: 33535184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma.
    Ma W; Liang J; Mo J; Zhang S; Hu N; Tian D; Chen Z
    BMC Cancer; 2021 Oct; 21(1):1096. PubMed ID: 34635082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BHLHE41/DEC2 Expression Induces Autophagic Cell Death in Lung Cancer Cells and Is Associated with Favorable Prognosis for Patients with Lung Adenocarcinoma.
    Nagata T; Minami K; Yamamoto M; Hiraki T; Idogawa M; Fujimoto K; Kageyama S; Tabata K; Kawahara K; Ueda K; Ikeda R; Kato Y; Komatsu M; Tanimoto A; Furukawa T; Sato M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCT5 interacts with cyclin D1 promoting lung adenocarcinoma cell migration and invasion.
    Meng Y; Yang L; Wei X; Luo H; Hu Y; Tao X; He J; Zheng X; Xu Q; Luo K; Yu G; Luo Q
    Biochem Biophys Res Commun; 2021 Aug; 567():222-229. PubMed ID: 34217974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.